Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Catholic MASTER cell
- Development stage
- Phase 2
- Lead developer
- The Catholic University of Korea Seoul St. Mary’s Hospital
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intraarticular
01
Overview
Catholic MASTER cell is a clinical-grade bone marrow-derived mesenchymal stem cell (BM-MSC) therapy developed by Catholic University of Korea. It is being investigated primarily for intra-articular injection in patients with knee osteoarthritis. The therapy involves injecting 1×10^8 cells/2cc directly into the knee joint of osteoarthritis patients.
Beyond the preview
Go deeper on Catholic MASTER cell.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Catholic MASTER cell.